Hormonal drugs.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001284:Atrophy / Q000139:chemically induced; D002843:Chromatin / Q000502:physiology; D003480:Cushing Syndrome / Q000209:etiology; D005347:Fibroblasts / Q000187:drug effects; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D005938:Glucocorticoids / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology*; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology; D011485:Protein Binding; D012869:Skin Absorption; D012871:Skin Diseases / Q000188:drug therapy*; D013329:Structure-Activity Relationship; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D002843:Chromatin; D005938:Glucocorticoids; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D006854:Hydrocortisone